SEC Comment Letter 0000000000-23-010555 to Aquestive Therapeutics, Inc. (AQST) (CIK 0001398733) (AQST)
Aquestive Therapeutics, Inc. (AQST) (CIK 0001398733)
Date: Sept. 25, 2023 · CIK: 0001398733 · Accession: 0000000000-23-010555
AI Filing Summary & Sentiment
File numbers found in text: 333-274609
Show Raw Text
United States securities and exchange commission logo
September 25, 2023
Lori J. Braender
Senior Vice President, General Counsel,
Aquestive Therapeutics, Inc.
30 Technology Drive
Warren, New Jersey 07059
Re:Aquestive Therapeutics, Inc.
Registration Statement on Form S-3
Filed September 21, 2023
File No. 333-274609
Dear Lori J. Braender:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika N. Sheppard at (202) 551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Anna Tomczyk, Esq